X0202 SCHEDULE 13G 0002147014 XXXXXXXX LIVE Common Stock , par value $0.0001 per share 07/02/2026 0001971387 Liminatus Pharma, Inc. 53271X108 2251 Stern Goodman Street, Suite E Fullerton CA 92833 Rule 13d-1(c) Samda Biolab Co., Ltd. M5 3426548.00 0.00 3426548.00 0.00 3426548.00 N 5.1 CO For Row 11, percentage is calculated based on 67,160,362 shares of Common Stock outstanding on July 2, 2026. Liminatus Pharma, Inc. 2251 Stern Goodman Street, Suite E, Fullerton, CA 92833 Samda Biolab Co., Ltd. #801 Factory building, 138, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea 10442 Republic of South Korea Y 3,426,548 5.1%* * Percentage is calculated based on 67,160,362 shares of Common Stock outstanding on July 2, 2026. 3,426,548 0 3,426,548 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Samda Biolab Co., Ltd. /s/ Beom K. Choi 07/22/2026